Results 121 to 130 of about 56,903 (251)

Dual Topical Therapy. The Future of Stretch Marks?

JEADV Clinical Practice, Volume 5, Issue 1, Page 26-31, March 2026.
ABSTRACT Striae distensae, or stretch marks, are linear scars that result from mechanical stretching of dermal tissue. They are most prevalent in women and in pregnancy, puberty, and obesity. The psychological and cosmetic symptoms may present a pathological synergy with the physical distress that stretch marks represent, especially if the patient is ...
Vicente Manuel Cisneros Rosell, Ramon Grimalt   +1 more
wiley   +1 more source

Unusual presentation of the apparent mineralocorticoid excess, triggered by mild Cushing[apos]s disease in an adult [PDF]

, 2015
Andrej Zavratnik, Matej Završnik, Urska Ksela, Evgenija Homšak, Antonela Sabati Rajic, Damien Gruson, Marija Pfeifer   +6 more
openalex   +1 more source

Remodeling the Inflammatory Microenvironment: Nanomaterial‐Based Targeted Strategies for Systemic Lupus Erythematosus and Lupus Nephritis

Small Science, Volume 6, Issue 3, March 2026.
Current treatments for severe lupus nephritis are limited by side effects due to poor drug targeting. This review explores how smart nanomaterials—like liposomes and biomimetic carriers—can precisely deliver drugs to overactive immune cells and the kidneys. These nanotherapeutics enhance efficacy, reduce toxicity, and enable combination strategies. The
Cheng Zhou, Jiayi Li, Jian Zhang, Haifeng Wang, Haitao Lu, Shunlai Shang, Wenge Li   +6 more
wiley   +1 more source

Genetics of Cushing 's disease

, 2022
Julia Simon, Marily Theodoropoulou
openalex   +1 more source

All Hazards Great and Small: Applying Disaster Risk Reduction to Environmental Justice Communities in South Carolina

GeoHealth, Volume 10, Issue 3, March 2026.
Abstract Community‐managed disaster risk reduction (CMDRR) puts communities at the center of disaster readiness by assessing hazards, vulnerabilities and capacities, conducting risk analyses, and implementing comprehensive disaster risk reduction (DRR) plans.
Daniel J. Kilpatrick, Keisha D. Long, Omar Muhammad, Dwayne E. Porter, Paul A. Sandifer, Karen Sprayberry, Katya Altman, Sean Briggs, Brooke Brittain, Nancy Button, John A. Cooper, Jeremy Cothran, Beata Dewitt, Tatiana DiSalvo, Herbert Fraser‐Rahim, Chaquetta Greene, Gary Harris, Kimberly Washok‐Jones, Sheila Kimble, Merrie Koester, Nikhil Kulkarni, Herbert Maybank, Michael McGirr, Jude Owoh, Robert Reese, Michele Schaafsma, Judith Day (Taylor), Heath Kelsey, Namita Koppa, Daphne Wilson   +29 more
wiley   +1 more source

Brief History of Spinal Neurosurgical Societies in the United States: Part 1. [PDF]

, 2019
Ames, Christopher P., Harrop, James S., Hoh, Daniel J., Resnick, Daniel K., Shaffrey, Christopher I., Singh, Kern, Smith, Justin S., Vaziri, Sasha   +7 more
core   +2 more sources

Benign Adrenal Adenomas Are Associated With Reduced Prevalence of Hospitalised Patients With COVID‐19

Clinical Endocrinology, Volume 104, Issue 3, Page 207-214, March 2026.
ABSTRACT Introduction Adrenal incidentalomas (AI) are commonly found on imaging done for indications other than to assess the adrenal glands. Prevalence increases with age and is around 10% in people over 80 years. The majority of AIs are benign adenomas, with 20%−50% exhibiting mild autonomous cortisol secretion (MACS).
Alan Kelsall, Chris Johns, Eleanor Hills, Jenny Zhao, John Newell‐Price   +4 more
wiley   +1 more source

Butyrate and mucosal inflammation: New scientific evidence supports clinical observation [PDF]

, 2015
Alvarado, David M., Ciorba, Matthew A., Cushing, Kelly   +2 more
core   +3 more sources

Efficacy and Tolerability of Metyrapone in Mild Autonomous Cortisol Secretion: Real‐World Findings From Clinical Practice

Clinical Endocrinology, Volume 104, Issue 3, Page 215-221, March 2026.
ABSTRACT Objective Mild autonomous cortisol secretion (MACS) is associated with increased cardiometabolic risk factors including hypertension, type 2 diabetes and dyslipidaemia. By using evening doses of metyrapone, a short‐acting 11‐β hydroxylase inhibitor, it has been shown that it is possible to reset the abnormal circadian cortisol rhythm in MACS ...
Simon Berry, Ahmed Iqbal, John Newell‐Price, Miguel Debono   +3 more
wiley   +1 more source

Resting Cerebrovascular Haemodynamics and Dynamic Assessment of Cerebrovascular Function in Polycystic Ovary Syndrome

Clinical Endocrinology, Volume 104, Issue 3, Page 245-254, March 2026.
ABSTRACT Objective Despite an increased cerebrovascular disease risk, the impact of Polycystic Ovary Syndrome (PCOS) on cerebrovascular haemodynamics and function is unknown. This study characterised cerebrovascular haemodynamics and function in women with PCOS versus healthy controls. Design Case‐control study.
Cory T. Richards, Thomas D. Griffiths, Zoe H. Adams, Melissa E. Wright, Saajan Davies, Jack S. Talbot, Lauren Broad‐Thomas, Diego García Esteban, Jessica J. Steventon, Patrice Brassard, Kevin Murphy, Philip E. James, D. Aled Rees, Rachel N. Lord   +13 more
wiley   +1 more source